always better to have 'material events' than Tweets or blogs

***** 7 weeks remaining w/ 12 milestone deliverables *****

2b.) LymPro - incl. patients w/ mild AZ, enrollment 68 patient LP-002 exten. (est. 4Q14)

03.) LymPro - JV Partnership Agreement (end of summer / rev. to est. 4Q14)

05.) LymPro - Partner valid. of APP & CLIA cert. (est. 4Q14)

06.) Eltoprazine - 200 patient Ph. 2b trial PD-LID (est. 4Q14)

07.) Eltoprazine - US IND filed & apvd. for PD-LID (est. 4Q14)

08.) MANF - Ophthalmological ear toxicology complete data sets (est. 4Q14)

10.) MANF / GDNF - Renishaw CED Ph. 2B test trial results (est. 4Q14)

12.) MANF OIS - Ocular Ischemic Syndrome - ODD applic. filed (est. 4Q14)

13.) MANF DB-1 Wolframs - Retinal eye data test results (est. 4Q14)

14.) MANF DB-1 Wolframs - orphan potential (est. 4Q14)

15.) MANF - Good Mfg. Practices (GMP) for 1st in-man studies (est. 4Q14)

25.) NASDAQ up-listing - (est. 4Q14)